New Study Confirms Long-Term Efficacy of HPV Vaccine
A new Swedish study has found that the HPV vaccine provides long-lasting protection against cervical cancer for at least 18 years, significantly reducing the risk.
2 stories found
A new Swedish study has found that the HPV vaccine provides long-lasting protection against cervical cancer for at least 18 years, significantly reducing the risk.

The Ghana Health Service (GHS) has officially incorporated the Human Papillomavirus (HPV) vaccine into the nation's routine immunisation programme.